BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 22352115)

  • 21. How are we creating fluoroquinolone-resistant tuberculosis?
    Bernardo J; Yew WW
    Am J Respir Crit Care Med; 2009 Aug; 180(4):288-9. PubMed ID: 19661251
    [No Abstract]   [Full Text] [Related]  

  • 22. [Difficulties in the treatment of pulmonary tuberculosis in children].
    Brînză N; Mihăescu T
    Rev Med Chir Soc Med Nat Iasi; 2007; 111(4):852-5. PubMed ID: 18389769
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug resistance to the first line of antitubercular regimen (a preliminary report).
    Varaiya A; Gogate A
    Indian J Public Health; 1998; 42(4):126-30. PubMed ID: 10389525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Shorter treatment of pulmonary tuberculosis is only acceptable with at least 4 drugs in the initial combination of tuberculostatic agents].
    Veen J
    Ned Tijdschr Geneeskd; 1996 Nov; 140(44):2164-7. PubMed ID: 8984351
    [No Abstract]   [Full Text] [Related]  

  • 25. Drug-resistant Mycobacterium tuberculosis, Taiwan.
    Jou R; Chuang PC; Wu YS; Yan JJ; Luh KT
    Emerg Infect Dis; 2006 May; 12(5):871-2. PubMed ID: 16710962
    [No Abstract]   [Full Text] [Related]  

  • 26. Recurrence after successful treatment among patients with multidrug-resistant tuberculosis.
    Lee J; Lim HJ; Cho YJ; Park YS; Lee SM; Yang SC; Yoo CG; Kim YW; Han SK; Yim JJ
    Int J Tuberc Lung Dis; 2011 Oct; 15(10):1331-3. PubMed ID: 22283890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Occurence of primary resistance in hospital patients with respiratory tuberculosis].
    Serdarević H; Bogdanović M; Travnik H; Simeonov L
    Tuberkuloza; 1966; 18(1-3):220-7. PubMed ID: 16296090
    [No Abstract]   [Full Text] [Related]  

  • 28. Drug resistant tuberculosis: back to sanatoria, surgery and cod-liver oil?
    Veen J
    Eur Respir J; 1995 Jul; 8(7):1073-5. PubMed ID: 7589389
    [No Abstract]   [Full Text] [Related]  

  • 29. [Usefulness of studies on antitubercular drug resistance].
    Valenzuela P
    Rev Panam Salud Publica; 1997 Jan; 1(1):62-7. PubMed ID: 9162582
    [No Abstract]   [Full Text] [Related]  

  • 30. Linezolid for multidrug-resistant tuberculosis.
    Chang KC; Leung CC; Daley CL
    Lancet Infect Dis; 2012 Jul; 12(7):502-3. PubMed ID: 22742623
    [No Abstract]   [Full Text] [Related]  

  • 31. [Respiratory fluoroquinolones and pulmonary tuberculosis treatment when the main drugs are ineffective].
    Lazareva NB; Khaĭmenova TIu; Khaĭmenov AIa
    Antibiot Khimioter; 2008; 53(5-6):14-20. PubMed ID: 19069177
    [No Abstract]   [Full Text] [Related]  

  • 32. Tuberculosis, drug resistance, and the history of modern medicine.
    Keshavjee S; Farmer PE
    N Engl J Med; 2012 Sep; 367(10):931-6. PubMed ID: 22931261
    [No Abstract]   [Full Text] [Related]  

  • 33. Mycobacterium tuberculosis drug-resistance in previously treated patients in Ouagadougou, Burkina Faso.
    Sangare L; Diande S; Kouanda S; Dingtoumda BI; Mourfou A; Ouedraogo F; Sawadogo I; Nebie B; Gueye A; Sawadogo LT; Traore AS
    Ann Afr Med; 2010; 9(1):15-9. PubMed ID: 20418644
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Linezolid in the treatment of drug-resistant tuberculosis: the way forward?
    Yew WW; Lange C
    Int J Tuberc Lung Dis; 2014 Jun; 18(6):631-2. PubMed ID: 24903928
    [No Abstract]   [Full Text] [Related]  

  • 35. Sulfamethoxazole susceptibility of Mycobacterium tuberculosis isolates from HIV-infected Ugandan adults with tuberculosis taking trimethoprim-sulfamethoxazole prophylaxis.
    Ogwang S; Good CE; Okware B; Nsereko M; Jacobs MR; Boom WH; Bark CM
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5844-6. PubMed ID: 26169400
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resistant plus susceptible tuberculosis: the undiscovered country.
    Ahmad Khan F; Behr M
    J Infect Dis; 2014 Jun; 209(11):1682-4. PubMed ID: 24523512
    [No Abstract]   [Full Text] [Related]  

  • 37. Direct observation therapy-plus can prevent acquired resistance to fluoroquinolones among patients with multidrug-resistant tuberculosis in Taiwan.
    Chien JY; Lai CC; Tan CK; Yu CJ; Hsueh PR
    Clin Infect Dis; 2013 Apr; 56(7):1054-5. PubMed ID: 23175554
    [No Abstract]   [Full Text] [Related]  

  • 38. DOTS and drug resistance: a silver lining to a darkening cloud.
    Chaisson RE; Coberly JS; De Cock KM
    Int J Tuberc Lung Dis; 1999 Jan; 3(1):1-3. PubMed ID: 10094162
    [No Abstract]   [Full Text] [Related]  

  • 39. [Report of drug resistance in strains of Mycobacterium tuberculosis isolated from patients in Iran].
    Bahrmand AR; Siadati A; Samar G; Sanami A
    Rev Cubana Med Trop; 1996; 48(2):92-7. PubMed ID: 9768277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Concomitant multidrug-resistant pulmonary tuberculosis and susceptible tuberculous meningitis.
    Bernard C; Brossier F; Fréchet-Jachym M; Morand PC; Coignard S; Aslangul E; Aubry A; Jarlier V; Sougakoff W; Veziris N
    Emerg Infect Dis; 2014 Mar; 20(3):506-7. PubMed ID: 24565423
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.